Research Article
Epidemiology and Survival Outcomes for Eyelid Primary Malignant Melanoma: An Analysis of 1397 Cases in the SEER Database
Table 3
Multivariate cox proportional hazard regression analysis of prognostic factors for OS and DSS of patients with eyelid PMM.
| Characteristics | OS | DSS | HR (95% CI) | value | HR (95% CI) | value |
| Race | | 0.232 | | 0.196 | Others | Reference | | Reference | | White | 0.825 (0.601–1.131) | 0.232 | 0.515 (0.188–1.409) | 0.196 |
| Age, y | | <0.001 | | <0.001 | 0–39 | Reference | | Reference | | 40–59 | 2.623 (1.387–4.960) | 0.003 | 2.022 (0.887–4.608) | 0.094 | 60–79 | 7.530 (4.072–13.926) | <0.001 | 1.823 (0.818–4.062) | 0.142 | 80+ | 24.216 (13.038–44.976) | <0.001 | 3.707 (1.640–8.381) | 0.002 |
| Histology | | 0.054 | | <0.001 | Malignant melanoma, NOS | Reference | | Reference | | LMM | 0.809 (0.652–1.004) | 0.055 | 0.243 (0.117–0.506) | <0.001 | SSM | 0.828 (0.656–1.046) | 0.113 | 0.514 (0.299–0.884) | 0.016 | NM | 1.192 (0.893–1.582) | 0.234 | 1.531 (0.921–2.545) | 0.100 |
| AJCC stage | | <0.001∗∗∗ | | <0.001 | I | Reference | | Reference | | II | 1.602 (1.142–2.246) | 0.006 | 3.738 (1.869–7.476) | <0.001 | III | 1.885 (1.277–4.051) | <0.001 | 5.397 (1.754–16.613) | 0.003 | IV | 6.183 (3.158–12.104) | <0.001 | 22.570 (8.589–59.312) | <0.001 |
| Stage at diagnosis | | <0.001 | | <0.001 | Localized | Reference | | Reference | | Regional | 1.983 (1.497–2.628) | <0.001 | 4.540 (2.781–7.411) | <0.001 | Distant | 3.906 (2.277–6.701) | <0.001 | 13.520 (6.870–26.604) | <0.001 |
| Metastasis at diagnosis | | 0.869 | | 0.963 | None | Reference | | Reference | | Distant | 1.440 (0.370–5.614) | 0.599 | 0.836 (0.130–5.381) | 0.851 |
| Surgery | | 0.361 | | 0.520 | No | Reference | | Reference | | Yes | 0.866 (0.637–1.179) | 0.361 | 0.821 (0.451–1.496) | 0.520 |
|
|
HR, hazard ratio; CI, confidence interval; PMM, primary malignant melanoma; NOS, not otherwise specified; LMM, lentigo malignant melanoma; SSM, superficial spreading melanoma; NM, nodular melanoma; OS, overall survival; DSS, disease-specific survival; AJCC, American Joint Committee on Cancer. Bold letter indicates statistical significance compared with references ( ). ; ; . |